These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 27125866)
1. NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells. Abd Ellah NH; Taylor L; Ayres N; Elmahdy MM; Fetih GN; Jones HN; Ibrahim EA; Pauletti GM Cancer Gene Ther; 2016 May; 23(5):149-55. PubMed ID: 27125866 [TBL] [Abstract][Full Text] [Related]
2. Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1. Wang SQ; Liu ST; Zhao BX; Yang FH; Wang YT; Liang QY; Sun YB; Liu Y; Song ZH; Cai Y; Li GF Oncotarget; 2015 Sep; 6(28):26142-60. PubMed ID: 26317651 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity. Wang Z; Zhang L; Ni Z; Sun J; Gao H; Cheng Z; Xu J; Yin P Tumour Biol; 2015 Dec; 36(12):9499-510. PubMed ID: 26124005 [TBL] [Abstract][Full Text] [Related]
4. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA. Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505 [TBL] [Abstract][Full Text] [Related]
5. Chemosensitization by diverging modulation by short-term and long-term TNF-α action on ABCB1 expression and NF-κB signaling in colon cancer. Walther W; Kobelt D; Bauer L; Aumann J; Stein U Int J Oncol; 2015 Dec; 47(6):2276-85. PubMed ID: 26463665 [TBL] [Abstract][Full Text] [Related]
6. Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer. Yuan ZT; Shi XJ; Yuan YX; Qiu YY; Zou Y; Liu C; Yu H; He X; Xu K; Yin PH Oncotarget; 2017 Jul; 8(29):48012-48026. PubMed ID: 28624793 [TBL] [Abstract][Full Text] [Related]
7. Extract of Bryophyllum laetivirens reverses etoposide resistance in human lung A549 cancer cells by downregulation of NF-κB. Kaewpiboon C; Srisuttee R; Malilas W; Moon J; Kaowinn S; Cho IR; Johnston RN; Assavalapsakul W; Chung YH Oncol Rep; 2014 Jan; 31(1):161-8. PubMed ID: 24220725 [TBL] [Abstract][Full Text] [Related]
8. Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression. Liu Z; Duan ZJ; Chang JY; Zhang ZF; Chu R; Li YL; Dai KH; Mo GQ; Chang QY PLoS One; 2014; 9(6):e98560. PubMed ID: 24901713 [TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells. Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704 [TBL] [Abstract][Full Text] [Related]
10. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway. Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091 [TBL] [Abstract][Full Text] [Related]
11. Reversion of P-gp-Mediated Drug Resistance in Ovarian Carcinoma Cells with PHPMA-Zosuquidar Conjugates. Battistella C; Klok HA Biomacromolecules; 2017 Jun; 18(6):1855-1865. PubMed ID: 28409628 [TBL] [Abstract][Full Text] [Related]
12. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance. Cao Z; Wright M; Cheng J; Huang X; Liu L; Wu L; Yang P Oncol Rep; 2014 Sep; 32(3):1211-7. PubMed ID: 25017650 [TBL] [Abstract][Full Text] [Related]
13. Imatinib resistance in multidrug-resistant K562 human leukemic cells. Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528 [TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
15. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633 [TBL] [Abstract][Full Text] [Related]
16. Nuclear Transcription Factor Kappa B Downregulation Reduces Chemoresistance in Bone Marrow-derived Cells Through P-glycoprotein Modulation. Loaiza B; Hernández-Gutierrez S; Montesinos JJ; Valverde M; Rojas E Arch Med Res; 2016 Feb; 47(2):78-88. PubMed ID: 27259382 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance. Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554 [TBL] [Abstract][Full Text] [Related]
18. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein. Si M; Zhao J; Li X; Tian JG; Li YG; Li JM Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684 [TBL] [Abstract][Full Text] [Related]
19. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Sui H; Zhou S; Wang Y; Liu X; Zhou L; Yin P; Fan Z; Li Q Carcinogenesis; 2011 May; 32(5):667-75. PubMed ID: 21296766 [TBL] [Abstract][Full Text] [Related]
20. Esters of the marine-derived triterpene sipholenol A reverse P-GP-mediated drug resistance. Zhang Y; Zhang YK; Wang YJ; Vispute SG; Jain S; Chen Y; Li J; Youssef DT; El Sayed KA; Chen ZS Mar Drugs; 2015 Apr; 13(4):2267-86. PubMed ID: 25874923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]